Compare VINP & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VINP | INMD |
|---|---|---|
| Founded | 2009 | 2008 |
| Country | Brazil | Israel |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 807.6M | 879.2M |
| IPO Year | 2020 | 2018 |
| Metric | VINP | INMD |
|---|---|---|
| Price | $12.75 | $15.17 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 6 |
| Target Price | $14.00 | ★ $16.75 |
| AVG Volume (30 Days) | 38.6K | ★ 1.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 4.78% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $66.95 | $3.80 |
| Revenue Next Year | $20.64 | $4.79 |
| P/E Ratio | $24.41 | ★ $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.66 | $13.16 |
| 52 Week High | $13.61 | $19.78 |
| Indicator | VINP | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 45.25 | 53.46 |
| Support Level | $11.90 | $14.23 |
| Resistance Level | $12.64 | $14.55 |
| Average True Range (ATR) | 0.41 | 0.54 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 39.25 | 35.48 |
Vinci Compass Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Equity, Equities, Real Assets, Credit, Global IP&S, and Corporate Advisory. The company's majority of its revenue comes from the Private Equity segment, which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.